• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Biotech investors remain cautious in a stabilizing funding environment

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 11, 2024 at 11:22: PM
via As biotechs pull resources out of thinner budgets, investors are still being cautious with their investments compared to funding highs seen a few years ago.

Experts deliberated the regulatory and financial factors influencing the current state of oncology clinical trials at the 13th Annual Clinical Trials in Oncology East Coast 2024 conference, being held 9 – 10 July in Burlington, Massachusetts.

article source
 




Top Bottom
Back
Quote